Brief: ALX Oncology Reports Second Quarter 2022 Results
08/08/2022 23:39
Aug 8 (Reuters) - ALX Oncology Holdings Inc ALXO.O :
* ALX ONCOLOGY REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
AND
PROVIDES CLINICAL DEVELOPMENT AND OPERATIONAL HIGHLIGHTS
* Q2 GAAP LOSS PER SHARE $0.81
* BELIEVES ITS CASH, CASH EQUIVALENTS AND INVESTMENTS ARE
SUFFICIENT TO FUND PLANNED OPERATIONS THROUGH Q4 OF 2024
Source text for Eikon: urn:newsml:reuters.com:*:nGNX9w0fVM
Further company coverage: ALXO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ALX Oncology Holdings
See all newsALX Oncology Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
ALX Oncology Holdings Inc expected to post a loss of 15 cents a share - Earnings Preview
ALX Oncology Q2 net loss narrows on lower R&D costs
Brief: ALX Oncology Q2 Basic EPS USD -0.13
Brief: Alx Oncology Holdings - Enters Loan And Security Agreement With HSBC Ventures On June 25, 2026 - SEC Filing